IP Library Granted Patent US 9,351,977
Granted Patent B2
US 9,351,977 · App. 14/920,192 · Granted May 31, 2016

Methods of reducing mammographic breast density and/or breast cancer risk

Inventor: Stephen Nigel Birrell (Piccadilly, AU)
Assignee: CHAVAH PTY LTD.
A61K31/568A61K31/4196
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,351,977
App. No.
14/920,192
Granted
May 31, 2016
Kind
B2
Abstract

The present disclosure is directed to generally methods for treating mammographic breast density and/or breast stiffness in a patient in need thereof, such as a premenopausal or perimenopausal patient, comprising the administration of an effective amount of androgenic agent and an effective amount of an aromatase inhibitor. These methods may also be useful in post-menopausal woman.

Claims (18)

1. A method of treating mammographic breast density and/or breast stiffness in a patient in need thereof, comprising administering to the patient a subcutaneous implant comprising:

i) an effective amount of testosterone; and

ii) 0.1-4 mg of anastrozole.

2. The method of claim 1 , wherein the patient is peri-menopausal.

3. The method of claim 1 , wherein the patient's breast has a mammographic breast density of 25% or greater.

4. The method of claim 1 , wherein the method enhances, increases, or improves, mammographic visualization or detection of the breast.

5. The method of claim 1 , wherein the method enhances, increases, or improves, breast compression during mammographic visualization or detection of the breast.

6. The method of claim 1 , wherein the method enhances, increases, or improves, the treated patient's compliance of having regular mammographic visualizations or detections.

7. The method of claim 1 , wherein the subcutaneous implant comprises:

i) 50-150 mg of the testosterone; and

ii) 1 mg, 2 mg, or 3 mg of the anastrozole.

8. The method of claim 7 , wherein the patient is premenopausal.

9. The method of claim 7 , wherein the patient is peri-menopausal.

10. The method of claim 7 , wherein the patient is post-menopausal.

11. The method of claim 7 , wherein the patient's breast has a BIRADS score of 3 or 4 (or c or d).

12. The method of claim 7 , wherein the patient's breast has a mammographic breast density of 7.5% or greater.

13. The method of claim 7 , wherein the method reduces or decreases the mammographic breast density of the patient's breast between one or more annual intervening mammographic detections.

14. The method of claim 7 , wherein the method reduces or decreases the breast stiffness of the patient's breast between one or more annual intervening mammographic detections.

Assignments (2)
CHANGE OF NAME Recorded Mar 19, 2018
From: CHAVAH PTY LTD.
To: HAVAH THERAPEUTICS PTY LTD.
Reel/Frame 045277/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2015
From: BIRRELL, STEPHEN NIGEL
To: CHAVAH PTY LTD.
Reel/Frame 037295/0915 →
Continuity (2)
Provisional Application 62067297 · Oct 22, 2014
Related Publication 20160113947A1 · Apr 28, 2016